WebJan 12, 2024 · Hypomagnesemia is often associated with hypokalemia (due to urinary potassium wasting) and hypocalcemia (due both to lower parathyroid hormone secretion and end-organ resistance to its effect). (See "Hypomagnesemia: Clinical manifestations of magnesium depletion" .) The major causes of hypomagnesemia will be reviewed in this … WebHypokalemia may develop with furosemide, especially with brisk diuresis, inadequate oral electrolyte intake, when cirrhosis is present, or during concomitant use of corticosteroids, ACTH, licorice in large amounts, or prolonged use of laxatives. ... There is a risk of ototoxic effects if cisplatin and furosemide are given concomitantly. In ...
FDA approves sodium thiosulfate to reduce the risk of ototoxicity ...
WebFirst-line multiagent chemotherapy comprises doxorubicin, cisplatin, and high-dose methotrexate (MAP regimen) . ... Regarding toxicity, rash and hypokalemia was the most common grade 3 adverse event, and one death from end organ failure was reported that was possibly related to the drug. http://www.bccancer.bc.ca/chemotherapy-protocols-site/Documents/Head%20and%20Neck/HNLAPRT_Protocol.pdf clinical labs locations victoria
Will you have Hypokalemia with Cisplatin - from FDA reports - eHe…
WebAug 1, 2004 · Nephrotoxicity after cisplatin administration usually manifests as increased serum creatinine and blood urea nitrogen (BUN) levels, as well as electrolyte … WebHypomagnesemia generally resolves with cessation of therapy. Cisplatin can cause increased magnesium losses by the kidneys as well as generalized decrease in kidney function. Magnesium loses can be severe and persist despite discontinuation of cisplatin. WebThere is no relationship between the presence or severity of Cisplatin side effects and effectiveness of cisplatin. The following side effects are common(occurring in greater than 30%) for patients taking Cisplatin: Nausea and vomiting. Nausea may last up … clinical labs locations sydney